His scientific interests lie mostly in Pathology, Epidermoid carcinoma, Cancer research, Carcinoma and Head and neck squamous-cell carcinoma. Gary L. Clayman combines subjects such as Tumor progression, Metastasis, Gene expression and Carcinogen with his study of Pathology. He interconnects Survival rate, Lesion, Surgery, Epidermal growth factor and Lymph node in the investigation of issues within Epidermoid carcinoma.
His Cancer research research incorporates themes from Cell culture, Mutation, Carcinogenesis, Tumor suppressor gene and Basal cell carcinoma. His Carcinoma study deals with the bigger picture of Internal medicine. His Head and neck squamous-cell carcinoma course of study focuses on Immunohistochemistry and Mouth neoplasm and Adverse effect.
Gary L. Clayman mainly focuses on Cancer research, Internal medicine, Pathology, Epidermoid carcinoma and Surgery. Gary L. Clayman works mostly in the field of Cancer research, limiting it down to concerns involving Genetic enhancement and, occasionally, Viral vector. His studies in Internal medicine integrate themes in fields like Gastroenterology, Endocrinology and Oncology.
His work carried out in the field of Pathology brings together such families of science as Cancer and Tumor progression. In his work, Molecular biology is strongly intertwined with Head and neck squamous-cell carcinoma, which is a subfield of Epidermoid carcinoma. His studies deal with areas such as Thyroid carcinoma and Neck dissection as well as Surgery.
His primary areas of study are Thyroid cancer, Thyroid carcinoma, Surgery, Internal medicine and Thyroid. The Thyroid cancer study combines topics in areas such as Fine-needle aspiration, Biopsy and Carcinoma, Neck dissection. His Thyroid carcinoma study incorporates themes from Dissection and Thyroidectomy.
He has included themes like Total thyroidectomy, Well-Differentiated Thyroid Cancer, Metastasis and Papillary thyroid cancer in his Surgery study. His Internal medicine research is multidisciplinary, incorporating elements of Endocrinology and Oncology. His Head and neck squamous-cell carcinoma study combines topics from a wide range of disciplines, such as Molecular biology, Cancer research, LEKTI and Cathepsin G.
His primary scientific interests are in Thyroid cancer, Carcinoma, Cancer, Surgery and Thyroid carcinoma. His Carcinoma research incorporates elements of Mutation, Gene, Survival analysis and Bioinformatics. Particularly relevant to Head and neck squamous-cell carcinoma is his body of work in Cancer.
His research investigates the connection between Head and neck squamous-cell carcinoma and topics such as Cancer research that intersect with issues in Kinase, Pathology and Oncogene. His research integrates issues of Papillary thyroid cancer and Thyroidectomy in his study of Surgery. The various areas that Gary L. Clayman examines in his Internal medicine study include Cell morphology and Oncology.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
Integrated Genomic Characterization of Papillary Thyroid Carcinoma
Nishant Agrawal;Rehan Akbani;B. Arman Aksoy;Adrian Ally.
Cell (2014)
Genetic progression model for head and neck cancer: Implications for field cancerization
Joseph Califano;Peter Van Der Riet;William Westra;Homaira Nawroz.
Cancer Research (1996)
Neck Dissection Classification Update: Revisions Proposed by the American Head and Neck Society and the American Academy of Otolaryngology–Head and Neck Surgery
K. Thomas Robbins;Gary L Clayman;Paul A. Levine;Jesus Medina.
Archives of Otolaryngology-head & Neck Surgery (2002)
Mutational Landscape of Aggressive Cutaneous Squamous Cell Carcinoma
Curtis R. Pickering;Jane H. Zhou;J. Jack Lee;Jennifer A. Drummond.
Clinical Cancer Research (2014)
Adenovirus-mediated p53 gene transfer in patients with advanced recurrent head and neck squamous cell carcinoma.
Gary L Clayman;Adel K. El-Naggar;Scott M. Lippman;Ying Cha Henderson.
Journal of Clinical Oncology (1998)
Mortality Risk From Squamous Cell Skin Cancer
Gary L. Clayman;J. Jack Lee;F. Christopher Holsinger;Xian Zhou.
Journal of Clinical Oncology (2005)
Epidermal Growth Factor Receptor-targeted Therapy with C225 and Cisplatin in Patients with Head and Neck Cancer
Dong M. Shin;Nicholas J. Donato;Roman Perez-Soler;Hyung Ju C. Shin.
Clinical Cancer Research (2001)
Polymorphisms of DNA repair gene XRCC1 in squamous cell carcinoma of the head and neck.
Erich M. Sturgis;Edward J. Castillo;Lei Li;Rong Zheng.
Carcinogenesis (1999)
In vivo molecular therapy with p53 adenovirus for microscopic residual head and neck squamous carcinoma
Gary L. Clayman;Adel K. El-Naggar;Jack A. Roth;Wei Wei Zhang.
Cancer Research (1995)
Growth Suppression of Human Head and Neck Cancer Cells by the Introduction of a Wild-Type p53 Gene via a Recombinant Adenovirus
Ta-Jen Liu;Wei-Wei Zhang;Dorothy L. Taylor;Jack A. Roth.
Cancer Research (1994)
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:
The University of Texas MD Anderson Cancer Center
University of California, San Diego
The University of Texas MD Anderson Cancer Center
The University of Texas MD Anderson Cancer Center
The University of Texas MD Anderson Cancer Center
The University of Texas MD Anderson Cancer Center
The University of Texas MD Anderson Cancer Center
The University of Texas MD Anderson Cancer Center
The University of Texas MD Anderson Cancer Center
The University of Texas MD Anderson Cancer Center
Yale University
University of Erlangen-Nuremberg
North Carolina State University
University of Tokushima
Chinese Academy of Sciences
Shivaji University
Mayo Clinic
Structural Genomics Consortium
Dong-A University
University of Bristol
Umeå University
Kent State University
Mayo Clinic
University of Nottingham
University of Minnesota
University of Alabama at Birmingham